Deutsche Supports Mallinckrodt/Sun Acquisition Merger

Mallinckrodt entered into an agreement to merge Sun Acquisition and Sucampo Pharmaceuticals. Deutsche Bank agented a $900 million revolving credit facility to support the transaction.

Deutsche Bank Provides $500MM Term Loan for Mallinckrodt Sucampo Purchase

Mallinckrodt agreed to acquire biopharmaceutical company Sucampo Pharmaceuticals, including its commercial and development assets, for $1.2 billion. The transaction was approved by the boards of directors of both companies.